Abstract

Background Natriuretic peptide receptors A (NPR-A) and B (NPR-B) are transmembrane guanylyl cyclases that regulate blood pressure, heart size and long bone growth. Unlike most cell surface receptors that are desensitized by direct phosphorylation, phosphorylation of natriuretic peptide receptors is essential for activation, and dephosphorylation causes their desensitization. While there are six and five known phosphorylation sites within NPR-A and NPRB, respectively, studies in homologous sea urchin guanylyl cyclase receptors indicate the presence of 15–17 moles of phosphate per mole of receptor, suggesting additional natriuretic peptide receptor phosphorylation sites remain to be identified. The purpose of this study was to identify novel natriuretic peptide receptor phosphorylation sites by evaluating functional consequences of individual glutamate or alanine substitutions of candidate residues in order to mimic the effects of a phosphorylated or dephosphorylated residue, respectively.

Highlights

  • Natriuretic peptide receptors A (NPR-A) and B (NPR-B) are transmembrane guanylyl cyclases that regulate blood pressure, heart size and long bone growth

  • 4th International Conference of cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2210-9-S1-info.pdf

  • While there are six and five known phosphorylation sites within NPR-A and NPRB, respectively, studies in homologous sea urchin guanylyl cyclase receptors indicate the presence of 15–17 moles of phosphate per mole of receptor, suggesting additional natriuretic peptide receptor phosphorylation sites remain to be identified

Read more

Summary

Open Access

Andrea R Yoder*1, Kathryn A Barbieri, Jerid W Robinson and Lincoln R Potter. Address: 1Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA and 2Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA. Published: 11 August 2009 BMC Pharmacology 2009, 9(Suppl 1):P76 doi:10.1186/1471-2210-9-S1-P76. 4th International Conference of cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2210-9-S1-info.pdf

Background
Conclusion
Methods and results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call